Results 321 to 330 of about 2,501,512 (375)

Cutaneous Administration of Nitroglycerin in Patients with Angina Pectoris

Angiology, 1981
M. Davidov
openaire   +4 more sources

Cutaneous reaction associated with weekly docetaxel administration

Journal of Oncology Pharmacy Practice, 2008
Background. Docetaxel-based chemotherapy will remain clinically relevant and many of our patients will continue to receive the drug. In a recent phase 2 study of docetaxel 35 mg/m2 (weekly) in patients with metastatic breast cancer, the incidence of grade 3 cutaneous toxicity is 19%.
Chew, L., Chuen, V.S.L.
openaire   +2 more sources

Biocompatible polymer-metal-organic framework composite patches for cutaneous administration of cosmetic molecules.

Journal of materials chemistry. B, 2016
Despite increasing interest in metal-organic frameworks (MOFs) in the biomedical field, developing specific formulations suitable for different administration routes is still a main challenge.
A. Márquez, T. Hidalgo, Hugo Lana, D. Cunha, M. Blanco-Prieto, C. Alvarez‐Lorenzo, C. Boissière, C. Sanchez, C. Serre, P. Horcajada   +9 more
semanticscholar   +1 more source

Levodopa Administration and Multiple Primary Cutaneous Melanomas

Archives of Dermatology, 1980
Malignant melanoma derives from melanocytic cells that possess the special biochemical pathway for the conversion of levodopa to melanin. Levodopa is widely employed in the treatment of Parkinson's disease, and several patients receiving levodopa have been observed to have acquired melanomas, raising concern about a possible relationship between this ...
Allan L. Lorincz, Anne E. Solomon, Maria Medenica, Joel E. Bernstein, Keyoumars Soltani   +4 more
openaire   +3 more sources

Characterization and release studies of liposomal gels containing glutathione/cyclodextrins complexes potentially useful for cutaneous administration.

Journal of Pharmacy and Science, 2014
The aim of this work is to develop and characterize a formulation intended for the cutaneous administration of glutathione (γ-glutamylcysteinylglycine, GSH), potentially useful for cellular defense against UV-induced damage.
A. Cutrignelli, A. Lopedota, N. Denora, V. Laquintana, S. Tongiani, M. Franco   +5 more
semanticscholar   +1 more source

Cutaneous calcinosis-an unusual complication of intravenous phosphate administration

Clinical and Experimental Dermatology, 1993
The case of an 80-year-old woman who developed extensive cutaneous calcification following intravenous phosphate administration is presented. Also the circumstances under which cutaneous calcification may occur are discussed.
C.M. Mills, A. G. Knight
openaire   +3 more sources

Cutaneous Atrophy Secondary to Intra-articular Corticosteroid Administration

Annals of Internal Medicine, 1966
Excerpt Intra-articular injection of adrenocorticosteroid has been shown to be a useful therapeutic procedure in the management of patients with rheumatoid arthritis.
Giles G. Bole, James T. Cassidy
openaire   +3 more sources

Selective Cutaneous Hyperpigmentation in Mice Following Zidovudine Administration

Archives of Dermatology, 1992
C57BL/6N mice fed zidovudine in their drinking water develop selective hyperpigmentation of the tails and footpads. Zidovudine-fed and identical control mice were observed and sequential biopsy specimens were obtained. Routine light microscopy, electron microscopy, and image analysis of unstained biopsy specimens were used to evaluate the extent ...
G Baker, Timothy G. Berger, T S Yen, M L Obuch, J Levin, R I Roth   +5 more
openaire   +2 more sources

Hepatotoxicity and cutaneous reactions after antithyroid drug administration

Clinical Endocrinology, 2012
SummaryObjectiveUse of the antithyroid drugs (ATDs) thiamazole (MMI) and propylthiouracil (PTU) is associated with a high frequency of side effects. When patients experience side effects with one (the 1st) ATD, it is usually discontinued and another is administered (the 2nd ATD).
Toshiko Chino, Koji Mukasa, Taeko Shimizu, Fumiko Otsuka, Matsuo Taniyama, Kunihiko Ito, Jaeduk Yoshimura Noh, Koichi Ito   +7 more
openaire   +3 more sources

High density lipoprotein subfractions during oral and cutaneous administration of 17 beta-estradiol to menopausal women.

Journal of Clinical Endocrinology and Metabolism, 1983
Thirty eight women with menopausal vasomotor symptoms were randomly allocated to 6 months treatment with either 2-4 mg micronized estradiol given orally or 3 mg estradiol applied cutaneously.
L. Fâhraeus, L. Wallentin
semanticscholar   +1 more source